Welcome to BlogNotions' Life Sciences Blog

The BlogNotions Life Sciences Blog delivers a diverse series of perspectives provided by thought leaders in the life sciences industries. Presented by NetLine, this forum delivers compelling updates on the latest technological advances, discussions of research and findings, best practices for advancing education, implications for the future of various life sciences fields, and much more. Here you can find helpful information, ask questions, and collaborate freely.

New molecule-building method may have great impact on pharmaceutical industry

Scientists at The Scripps Research Institute (TSRI) have devised a new molecule-building method that is likely to have a major impact on the pharmaceutical industry and many other chemistry-based enterprises. The method, published as an online First Release paper in Science on April 21, 2016, allows chemists to construct novel, complex and potentially very valuable molecules, starting […]

Continue Reading

Drug Patent Expirations for Aug 18, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. KALETRA (lopinavir; ritonavir) Abbvie Patent number: 6,284,767 Expiration Date: Aug 15, 2016 TESTODERM (testosterone) Alza Patent number: 5,840,327 Expiration Date: Aug 15, 2016 ENABLEX (darifenacin hydrobromide) […]

Continue Reading

Soy shows promise as natural anti-microbial agent

In continuation of my update on soy Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers. Soybean derivatives are already a mainstay in food products, such as cooking oils, cheeses, ice cream, margarine, food spreads, canned foods and baked […]

Continue Reading

New drug combination before surgery may improve outcomes in breast cancer patients

  In continuation of my update on Paclitaxel  Results from the I-SPY 2 trial show that giving patients with HER2-positive invasive breast cancer a combination of the drugs trastuzumab emtansine (T-DM1) and pertuzumab before surgery was more beneficial than the combination of paclitaxel plus trastuzumab. Previous studies have shown that a combination of T-DM1 and pertuzumab […]

Continue Reading

Experimental treatment shrinks rare pediatric tumor by 90%

 In continuation of my update on LOXO-101 When a baby’s life was threatened by a rare pediatric cancer that would not respond to surgery or chemotherapy, doctors at Nemours Children’s Hospital rapidly, successfully shrank the tumor by 90 percent using an experimental treatment, according to a new study published online in Pediatric Blood and Cancer. […]

Continue Reading

Scientists develop new drug for life-threatening lung disease treatment

Researchers are developing a new drug to treat life-threatening lung damage and breathing problems in people with severe infections like pneumonia, those undergoing certain cancer treatments and premature infants with underdeveloped, injury prone lungs. Scientists at Cincinnati Children’s Hospital Medical Center report April 19 in Science Signaling that a transcription factor called FOXF1 activates several […]

Continue Reading

Drug Patent Expirations for Aug 11, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. KAZANO (alogliptin benzoate; metformin hydrochloride) Takeda Pharms Usa Patent number: 6,303,640 Expiration Date: Aug 9, 2016 DUETACT (glimepiride; pioglitazone hydrochloride) Takeda Pharms Usa Patent number: 6,303,640 […]

Continue Reading